Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202153334> ?p ?o ?g. }
- W3202153334 endingPage "182" @default.
- W3202153334 startingPage "149" @default.
- W3202153334 abstract "A gluten-free diet (GFD) is the current standard of care for all patients with celiac disease (CeD) including its classic, nonclassic, and silent forms, as well as for dermatitis herpetiformis, gluten ataxia, and nonceliac gluten sensitivity. Following a GFD involves restricting certain food items, thus care must be taken to ensure a balanced diet that provides both macronutrients and micronutrients. Further, a GFD requires major lifestyle changes for the patients and their families. Moreover, despite attempts to maintain a strict GFD, gluten exposure is common given the extensive use of gluten in the food industry. Hence, repeated and accurate counseling of patients and their families by skilled/specialized dieticians forms an essential part of the treatment. Other best practices to be considered by physicians include monitoring and correction of nutritional deficiencies related to CeD, prevention of bone loss, vaccinations for certain infections, voluntary screening of family members, and keeping a high index of suspicion for CeD-associated autoimmune disorders and extraintestinal manifestations affecting the liver, bone, etc. All patients with CeD should be assessed at regular intervals for improvement and adherence on a GFD, since almost a third of patients fail to show a satisfactory response. Monitoring and appropriate treatment of issues uniquely associated with a GFD, including a higher risk of metabolic syndrome, fatty liver, dietary deficiencies, and constipation, are also important. Interestingly, insights gleaned into the pathogenesis of CeD over the past two decades have provided options for targeted therapies that may be useful as alternatives/adjunctive to a GFD. Based on their mechanisms of action, these therapies may be classified as belonging to one of the following approaches. The first approach involves decreasing the immunogenicity of gluten, using glutenases like latiglutenase or kuma, genetic modification of wheat that is the most common source of gluten, microwave thermal treatment of hydrated wheat kernels, and gluten pretreatment prior to ingestion, with either bacterial/fungal-derived endopeptidases or microbial transglutaminase. The second approach involves intraluminal gluten-binding drugs like polymer p(HEMA-co-SS), single-chain fragment variable, and antigluten antibody AGY. The third approach antagonizes zonulin, a molecule regulating intestinal epithelial tight junctions that mediate gliadin transport. The fourth approach involves intestinal tissue transglutaminase enzyme inhibition to decrease deamidation of gliadin peptides taken-up by the mucosa, into epitopes with enhanced immunogenicity, using agents like ZED1227, si-RNA therapy, etc. The fifth approach seeks to prevent downstream immune activation after exposure to gliadin peptides, using Human Leukocyte Antigen blockers that prevent presentation of gluten-derived antigens by dendritic cells to T cells, immune-tolerizing therapies like the vaccine Nexvax2 and the nanoparticle-based Tolerogenic Immune Modifying Particles-Glia, cathepsin inhibitors, corticosteroids, elafin, etc., and anticytokine agents targeting interleukin-15/interleukin-21, CCR9–CCL25 interaction, γc receptor, etc. Overall, among the novel therapies on the anvil, glutenases, and strategies that modulate immune activation appear to be some of the promising therapies based on preliminary results." @default.
- W3202153334 created "2021-10-11" @default.
- W3202153334 creator A5037903266 @default.
- W3202153334 creator A5059852221 @default.
- W3202153334 date "2022-01-01" @default.
- W3202153334 modified "2023-09-26" @default.
- W3202153334 title "Treatment of gluten-related disorders" @default.
- W3202153334 cites W1048319471 @default.
- W3202153334 cites W1503438575 @default.
- W3202153334 cites W1540991136 @default.
- W3202153334 cites W1565636942 @default.
- W3202153334 cites W1817163397 @default.
- W3202153334 cites W1829424702 @default.
- W3202153334 cites W1896583420 @default.
- W3202153334 cites W1964322411 @default.
- W3202153334 cites W1965727970 @default.
- W3202153334 cites W1966141691 @default.
- W3202153334 cites W1967357905 @default.
- W3202153334 cites W1975291041 @default.
- W3202153334 cites W1975783620 @default.
- W3202153334 cites W1978741239 @default.
- W3202153334 cites W1979031540 @default.
- W3202153334 cites W1983001695 @default.
- W3202153334 cites W1983459546 @default.
- W3202153334 cites W1983742961 @default.
- W3202153334 cites W1984276265 @default.
- W3202153334 cites W1985116046 @default.
- W3202153334 cites W1986115076 @default.
- W3202153334 cites W1991013976 @default.
- W3202153334 cites W1991535507 @default.
- W3202153334 cites W1991861037 @default.
- W3202153334 cites W1995018459 @default.
- W3202153334 cites W1995488307 @default.
- W3202153334 cites W1998194286 @default.
- W3202153334 cites W1999919932 @default.
- W3202153334 cites W2001745097 @default.
- W3202153334 cites W2004298900 @default.
- W3202153334 cites W2005492996 @default.
- W3202153334 cites W2007153997 @default.
- W3202153334 cites W2010227424 @default.
- W3202153334 cites W2012930180 @default.
- W3202153334 cites W2015222768 @default.
- W3202153334 cites W2016811628 @default.
- W3202153334 cites W2020626093 @default.
- W3202153334 cites W2022106531 @default.
- W3202153334 cites W2023349848 @default.
- W3202153334 cites W2023540595 @default.
- W3202153334 cites W2023945968 @default.
- W3202153334 cites W2024894443 @default.
- W3202153334 cites W2025312618 @default.
- W3202153334 cites W2027640022 @default.
- W3202153334 cites W2029668047 @default.
- W3202153334 cites W2030810018 @default.
- W3202153334 cites W2032916583 @default.
- W3202153334 cites W2036417799 @default.
- W3202153334 cites W2037877241 @default.
- W3202153334 cites W2039229476 @default.
- W3202153334 cites W2043320911 @default.
- W3202153334 cites W2044830949 @default.
- W3202153334 cites W2048340869 @default.
- W3202153334 cites W2048720554 @default.
- W3202153334 cites W2049422375 @default.
- W3202153334 cites W2053900723 @default.
- W3202153334 cites W2054234285 @default.
- W3202153334 cites W2056457466 @default.
- W3202153334 cites W2056478385 @default.
- W3202153334 cites W2057256555 @default.
- W3202153334 cites W2058103932 @default.
- W3202153334 cites W2058810145 @default.
- W3202153334 cites W2061478907 @default.
- W3202153334 cites W2064029207 @default.
- W3202153334 cites W2065406132 @default.
- W3202153334 cites W2065817253 @default.
- W3202153334 cites W2067307549 @default.
- W3202153334 cites W2068848860 @default.
- W3202153334 cites W2071596061 @default.
- W3202153334 cites W2071838153 @default.
- W3202153334 cites W2072694109 @default.
- W3202153334 cites W2073685805 @default.
- W3202153334 cites W2075805805 @default.
- W3202153334 cites W2076331472 @default.
- W3202153334 cites W2079813087 @default.
- W3202153334 cites W2080986266 @default.
- W3202153334 cites W2081878625 @default.
- W3202153334 cites W2083562009 @default.
- W3202153334 cites W2083649427 @default.
- W3202153334 cites W2084228983 @default.
- W3202153334 cites W2085966326 @default.
- W3202153334 cites W2087226049 @default.
- W3202153334 cites W2090456989 @default.
- W3202153334 cites W2091102092 @default.
- W3202153334 cites W2091204354 @default.
- W3202153334 cites W2093390011 @default.
- W3202153334 cites W2093809358 @default.
- W3202153334 cites W2094130811 @default.
- W3202153334 cites W2094242636 @default.
- W3202153334 cites W2094306125 @default.
- W3202153334 cites W2096497879 @default.